Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision‐Making Pathway

Background Oral anticoagulation reduces stroke and disability in atrial fibrillation (AF) but is underused. We evaluated the effects of a novel patient‐clinician shared decision‐making (SDM) tool in reducing oral anticoagulation patient's decisional conflict as compared with usual care. Methods...

Full description

Bibliographic Details
Published in:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Main Authors:	Paul J. Wang, Ying Lu, Kenneth W. Mahaffey, Amy Lin, Daniel P. Morin, Samuel F. Sears, Mina K. Chung, Andrea M. Russo, Bryant Lin, Jonathan Piccini, Mellanie True Hills, Caroline Berube, Krishna Pundi, Tina Baykaner, Gotzone Garay, Karma Lhamo, Eli Rice, Idean A. Pourshams, Rushil Shah, Paul Newswanger, Katie DeSutter, Julio Cesar Nunes, Michelle A. Albert, Kevin A. Schulman, Paul A. Heidenreich, T. Jared Bunch, Lee M. Sanders, Mintu Turakhia, Abraham Verghese, Randall S. Stafford
Format:	Article
Language:	English
Published:	Wiley 2023-02-01
Subjects:	anticoagulants anticoagulation atrial fibrillation decisional conflict digital health shared decision making
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.122.028562

Similar Items

Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin
by: Krishna N. Pundi, et al.
Published: (2021-12-01)

Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation
by: Celina M. Yong, et al.
Published: (2020-05-01)

Potential for a Virtual Care Model in the Perioperative Management of Anticoagulant Therapy: A 5-Year Retrospective Clinic Review
by: Douketis Douketis, et al.
Published: (2023-07-01)

Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration
by: Ryan T. Borne, et al.
Published: (2017-09-01)

Differences in Preferences Between Clinicians and Patients for the Use and Dosing of Direct Oral Anticoagulants for Atrial Fibrillation
by: Jennifer A. Rymer, et al.
Published: (2021-06-01)

The new, direct, target-specific oral anticoagulants
by: Nevine A Kassim
Published: (2015-01-01)

Resolution of the International meeting of experts on the exchange of scientific experience in the use of anticoagulants in patients with COVID-19
by: S. N. Avdeev, et al.
Published: (2020-09-01)

Updates in Anticoagulation Therapy Monitoring
by: Hannah L. McRae, et al.
Published: (2021-03-01)

The effect of oral anticoagulant use before visit for patients with COVID-19 on mortality: A meta-analysis
by: Cornelia Ghea, et al.
Published: (2023-01-01)

SPECIFICITY OF ANTICOAGULANT CHOICE FOR VTE PROPHYLAXES AFTER MAJOR ORTHOPEDIC SURGERY- THE VIEW OF CLINICAL PHARMACOLOGISTS
by: S. A. Bozhkova
Published: (2011-03-01)

Liver function after transplantation in the assessment of the coagulation system and the concept of antithrombotic therapy
by: Marceli Lukaszewski, et al.
Published: (2020-03-01)

A Deep Overview of Anticoagulant Drugs: Recent Synthesis and Their Activity Assay
by: Engrid Juni Astuti, et al.
Published: (2024-04-01)

Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines‐Atrial Fibrillation
by: Frederik Dalgaard, et al.
Published: (2020-12-01)

Possible Factor Xa Resistance in a Patient Who Failed Apixaban and Rivaroxaban
by: Ola Ali, et al.
Published: (2024-12-01)

Fondaparinux Outpatient Use for Patients with a Heparin-Induced Thrombocytopenia History: A Case Report and Review
by: Amy Christopher
Published: (2016-12-01)

Modern Anticoagulant Therapy for Atrial Fibrillation: Patient Adherence in Clinical Practice
by: Yu. P. Skirdenko, et al.
Published: (2022-03-01)

Evidence Gaps in the Era of Non–Vitamin K Oral Anticoagulants
by: Konstantinos N. Aronis, et al.
Published: (2018-02-01)

Problematic points of anticoagulant therapy for atrial fibrillation in certain Russian regions in 2016- 2019: results of a retrospective big data analysis
by: M. A. Druzhilov, et al.
Published: (2024-10-01)

Re-starting anticoagulation and antiplatelets after gastrointestinal bleeding: A systematic review [version 1; peer review: 2 approved]
by: Sneha Thomas, et al.
Published: (2023-07-01)

Inhospital outcomes of myocardial infarction in patients receiving direct oral anticoagulants
by: M. G. Chashchin, et al.
Published: (2023-11-01)

EXTENDED THERAPY OF VENOUS THROMBOSIS BY ORAL ANTICOAGULANTS: FOCUS AT SAFETY
by: I. V. SCHASTLIVTSEV, et al.
Published: (2016-12-01)

State and adequacy of anticoagulant therapy in fibrillation of precurities in clinical practice
by: A. A. Tuchkov, et al.
Published: (2021-06-01)

Direct oral anticoagulants for electrical cardioversion
by: A. N. Volovchenko, et al.
Published: (2021-07-01)

Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation
by: Sabine F. B. van der Horst, et al.
Published: (2023-07-01)

Oral anticoagulation related intracerebral hemorrhage: more questions than answers
by: Elena Terecoasa, et al.
Published: (2012-03-01)

Acute coronary syndrome in a patient with transient ischemic attack: challenges of antithrombotic therapy (a clinical case)
by: E. Yu. Kovalchuk, et al.
Published: (2019-12-01)

Characterizing anticoagulation reversal practices in Colombia: Initial insights from a national registry
by: Sebastián Seni-Molina, et al.
Published: (2025-09-01)

DIRECT ORAL ANTICOAGULANTS
by: I. Tzoran, et al.
Published: (2016-06-01)

Pathways for lower extremity superficial vein thrombosis management in an academic medical center
by: Gisoo Imani, et al.
Published: (2025-03-01)

Direct oral anticoagulants (DOACs): From the laboratory point of view
by: Margetić Sandra, et al.
Published: (2022-12-01)

A Literature Review of Pathophysiology, Clinical Manifestations, Medications and Optimal Dosage, Outpatient, and Post-hospitalization Use of Anticoagulation in COVID-19 Patients
by: Dimitrios Velissaris, et al.
Published: (2023-04-01)

Direct oral anticoagulants versus warfarin in adult heart transplant recipients
by: Lauren Shitanishi, PharmD, et al.
Published: (2024-05-01)

Practical Considerations for Use of Direct Oral Anticoagulants in Children
by: Hilary Whitworth, et al.
Published: (2022-04-01)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2020-05-01)

EXPERIENCE IN THE USE OF ORAL ANTICOAGULANTS IN OUTPATIENT CLINICS
by: T. V. Voskresenskaya, et al.
Published: (2017-11-01)

Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT‐AF
by: Emily C. O'Brien, et al.
Published: (2018-06-01)

Attitude to clinical research among health professionals affiliated with the Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA)
by: Daniela Poli, et al.
Published: (2023-03-01)

Α 6-month, multicenter, observational study investigating the treatment of venous thromboembolism in Greece (VICTORIA study)
by: Paraskevi Savvari, et al.
Published: (2025-06-01)

Biological activity of fucoidan from leafy bladderwort (Utricularia aurea Lour.)
by: Chotigeat, W., et al.
Published: (2005-12-01)

Carbamazepine, phenytoin, and oral anticoagulants: Drug‐drug interaction and clinical events in a retrospective cohort
by: Matteo Candeloro, et al.
Published: (2022-02-01)